Lezack Adam 4
4 · Beta Bionics, Inc. · Filed Dec 2, 2025
Insider Transaction Report
Form 4
Lezack Adam
Director
Transactions
- Sale
Common Stock
2025-12-01$29.35/sh−906$26,588→ 8,935 total - Sale
Common Stock
2025-12-01$29.91/sh−500$14,955→ 8,435 total
Footnotes (3)
- [F1]Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025.
- [F2]The weighted average sale price for the transaction reported was $29.3463 and the range of prices were between $28.75 and $29.63. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The weighted average sale price for the transaction reported was $29.91 and the range of prices were between $29.80 and $30.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.